124 million people affected worldwide 1
Borderline personality disorder causes significant impairment and distress and is associated with multiple medical and psychiatric co-morbidities.
Current Treatments 1
Treatment for borderline personality disorder currently consists of psychotherapy and can include medication. Several talk therapy methods such as dialectical behaviour therapy and schema-focused therapy can be used. There is no medication approved for borderline, but this can be given for co-morbid depression or other disorders.
Psychedelic research currently is in Phase IIa
Only one trial with psychedelics has recently started. This trial will look at psilocybin for borderline in combination with depression. Anecdotal evidence points towards positive effects of psychedelices.
Though not studied nearly enough, some psychedelics (mainly ketamine) are being researched to help those with borderline. One trial is ongoing to study the effects of psilocybin on borderline that co-occurs with depression.
This topic is currently a stub, it will be expanded upon in the near future.
Highlighted Institutes
These are the institutes, from companies to universities, who are working on Borderline.
Highlighted People
These are some of the best-known people, from researchers to entrepreneurs, working on Borderline.
Linked Research Papers about Borderline
MDMA-Assisted Psychotherapy for Borderline Personality Disorder
Ayahuasca: pharmacology, neuroscience and therapeutic potential
Ayahuasca improves emotion dysregulation in a community sample and in individuals with borderline-like traits
A pilot randomized controlled trial of ketamine in Borderline Personality Disorder